Metizolam (also known as desmethyletizolam) is a thienotriazolodiazepine that is the demethylated analogue of the closely related etizolam.

[1][2][3][4][5][6] Following its sale as a designer drug,[7] metizolam was classified as controlled substance in Sweden on 26.

January 2016.

[8] This sedative-related article is a stub.

You can help Wikipedia by expanding it.